 no signiÔ¨Åcant difference was seen
when compared with endovenous laser ablation (EVLA) at 5 years. UGFS was associated with an increased risk of recurrence
compared with HL/S. EVLA was associated with lower anatomic closure rates at 30 days than cyanoacrylate closure (CAC)
and higher rates at one and 5 years when compared with UGFS. Thermal interventions were associated with lower generic
quality of life scores and an